Introduction：Basic information about CAS 504-07-4|Dihydrouracil, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Dihydrouracil |
|---|
| CAS Number | 504-07-4 | Molecular Weight | 114.103 |
|---|
| Density | 1.6±0.1 g/cm3 | Boiling Point | 337.0±25.0 °C at 760 mmHg |
|---|
| Molecular Formula | C4H6N2O2 | Melting Point | 279-281 °C(lit.) |
|---|
| MSDS | / | Flash Point | 208.5±12.4 °C |
|---|
Names
| Name | 5,6-dihydrouracil |
|---|
| Synonym | More Synonyms |
|---|
Dihydrouracil BiologicalActivity
| Description | 5,6-Dihydrouracil is an intermediate breakdown product of uracil. |
|---|
| Related Catalog | Research Areas >>OthersNatural Products >>Others |
|---|
| Target | Human Endogenous Metabolite |
|---|
Chemical & Physical Properties
| Density | 1.6±0.1 g/cm3 |
|---|
| Boiling Point | 337.0±25.0 °C at 760 mmHg |
|---|
| Melting Point | 279-281 °C(lit.) |
|---|
| Molecular Formula | C4H6N2O2 |
|---|
| Molecular Weight | 114.103 |
|---|
| Flash Point | 208.5±12.4 °C |
|---|
| Exact Mass | 114.042931 |
|---|
| PSA | 58.20000 |
|---|
| LogP | -1.83 |
|---|
| Vapour Pressure | 0.0±1.7 mmHg at 25°C |
|---|
| Index of Refraction | 1.649 |
|---|
| InChIKey | OIVLITBTBDPEFK-UHFFFAOYSA-N |
|---|
| SMILES | O=C1CCNC(=O)N1 |
|---|
Safety Information
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|
| Hazard Codes | Xi |
|---|
| Safety Phrases | S24/25 |
|---|
| RIDADR | NONH for all modes of transport |
|---|
| WGK Germany | 3 |
|---|
| HS Code | 2933599090 |
|---|
Customs
| HS Code | 2933599090 |
|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|---|
Articles50
More Articles
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231) , 910-4, (2009) Multiple, complex molecular events characterize cancer development and progression. Deciphering the molecular networks that distinguish organ-confined disease from metastatic disease may lead to the i... | |
| Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine. Kidney Int. 79(11) , 1244-53, (2011) Autosomal dominant polycystic kidney disease (ADPKD) is a frequent cause of kidney failure; however, urinary biomarkers for the disease are lacking. In a step towards identifying such markers, we used... | |
| Aberrant repair initiated by mismatch-specific thymine-DNA glycosylases provides a mechanism for the mutational bias observed in CpG islands. Nucleic Acids Res. 42(10) , 6300-13, (2014) The human thymine-DNA glycosylase (TDG) initiates the base excision repair (BER) pathway to remove spontaneous and induced DNA base damage. It was first biochemically characterized for its ability to ... | |
Synonyms
| dihydropyrimidine-2,4(1H,3H)-dione |
| T6MVMVTJ |
| EINECS 207-982-1 |
| Dihydrouracil |
| 2,4(1H,3H)-Pyrimidinedione, dihydro- |
| 5,6-DIHYDROURACIL |
| Dihydro-2,4(1H,3H)-pyrimidinedione |
| 1,3-diazinane-2,4-dione |
| MFCD00006029 |
